Search results for Multiple Sclerosis.
Found 8 clinical studies.
An Integrative Computational Multimodal Approach To Disentangle Pathophysiologic Heterogeneity Of Age-Related White Matter Hyperintensities
- Investigator: Matthew Flaherty
- Posted Date: Jul 11, 2025
- Type of Study: Observational/Survey
A Phase 2, Randomized, Double-Blind, Four-Arm, Placebo-Controlled, Multicenter Study Assessing The Efficacy, Safety And Tolerability Of Three Doses Of Orally Administered Bms-986368, A Faah/Mgll Inhibitor, For The Treatment Of Spasticity In Participants W
- Investigator: Shahla Hosseini
- Posted Date: Apr 30, 2025
- Type of Study: Drug
A Randomized, Open-Label, Parallel-Group, Non-Inferiority Study Comparing Efficacy, Safety, And Tolerability Of Remibrutinib After Switching From Ocrelizumab In Participants Living With Relapsing Multiple Sclerosis, Followed By Open-Label Treatment With R
- Investigator: Aram Zabeti
- Posted Date: Apr 28, 2025
- Type of Study: Drug
Evaluating Efficacy When Transitioning From A Current Disease Modifying Therapy 9Dmt) To Ublituximab (Enhance)
- Investigator: Lawrence Goldstick
- Posted Date: Jul 15, 2024
- Type of Study: Drug
Phase 1/2, Two-Part, Open-Label Dose-Escalation And Double-Blind, Placebo-Controlled Dose-Expansion Study With An Open-Label Extension To Evaluate The Safety And Efficacy Of Ata188 In Subjects With Progressive Multiple Sclerosis
- Investigator: Aram Zabeti
- Posted Date: Jun 22, 2021
- Type of Study: Drug
An Open-Label, Multicenter Phase 4 Study To Assess Disease Activity And Biomarkers Of Neuronal Damage In Minority Patients With Relapsing Multiple Sclerosis Receiving Treatment With Ocrelizumab
- Investigator: Lawrence Goldstick
- Posted Date: Mar 19, 2021
- Type of Study: Drug
Bn42083 A Phase IIIb Multicenter, Randomized, Double-Blind, Controlled Study To Evaluate The Efficacy, Safety And Pharmacokinetics Of A Higher Dose Of Ocrelizumab In Adults With Primary Progressive Multiple Sclerosis
- Investigator: Aram Zabeti
- Posted Date: Feb 15, 2021
- Type of Study: Drug
Gn42272: A Phase III Randomized, Double-Blind Study To Evaluate Efficacy And Safety Of Fenebrutinib Compared With Teriflunomide In Patients With Relapsing Multiple Sclerosis
- Investigator: Aram Zabeti
- Posted Date: Oct 23, 2020
- Type of Study: Drug